PN

Pragati Nalini Pati

Active Director Additional Director DIN 11260086
DIN 11260086 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pragati Nalini Pati

Data last updated:

Pragati Nalini Pati is an Additional Director at Pragnya Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11260086
Primary Designation Additional Director
Industry Pharma
First Appointment 26 Aug 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director26 Aug 2025Active

Board colleagues of Pragati Nalini Pati

Directorship timeline

Open interactive timeline →
Pragnya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pragati Nalini Pati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pragati Nalini Pati

Pragati Nalini Pati currently holds 1 directorship: Pragnya Pharmaceuticals Private Limited (Additional Director, since 26 Aug 2025).

Pragati Nalini Pati was first appointed on 26 Aug 2025 as Additional Director at Pragnya Pharmaceuticals Private Limited.

The current boards of Pragati Nalini Pati's companies include Aryamaan Santuka (Pragnya Pharmaceuticals Private Limited), Pravesh Kyal (Pragnya Pharmaceuticals Private Limited), Sanjaya Kumar Patra (Pragnya Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available